A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

CompletedOBSERVATIONAL
Enrollment

191

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

July 6, 2023

Study Completion Date

August 28, 2023

Conditions
Multiple Myeloma
Interventions
OTHER

No Intervention

This is a non-interventional study.

Trial Locations (20)

14068

Hallym University Sacred Heart Hospital, Anyang

14584

SOONCHUNHYANG UNIVERSITY HOSPITAL Bucheon, Bucheon-si

16499

Ajou University Hospital, Suwon

16995

Yongin Severance Hospital, Yŏngin

21431

The Catholic University of Korea, Incheon ST. Marys Hospital, Incheon

26426

Yonsei University Wonju Severance Christian Hospital, Wŏnju

35015

Chungnam National Unversity Hospital, Daejeon

41944

Kyungpook National University Hospital, Daegu

42601

Keimyung University Dongsan Hospital, Daegu

47392

Inje University Busan Paik Hospital, Busan

49241

Pusan National University Hospital, Busan

49267

Kosin University Gospel Hospital, Busan

58128

Chonnam National University Hwasun Hospital, Hwasun

02841

Korea University Anam Hospital, Seoul

03080

Seoul National University Hospital, Seoul

06351

Samsung medical center, Seoul

06591

The Catholic University of Korea Seoul ST. Mary's Hospital, Seoul

06973

Chung-Ang University Hospital, Seoul

07985

Ewha womans university medical center, Seoul

08308

Korea University Guro Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY